Light therapy study sheds light on immune changes in transplant complication
NCT ID NCT03438643
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how extracorporeal photopheresis (ECP) — a treatment that uses light to modify a patient's own blood cells — affects the immune system in people with chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. Only 8 people were enrolled before the study was stopped early. The goal was to understand why ECP helps some patients, not to test a cure or new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Claude Huriez, CHU
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can meditation tame the Long-Term side effects of a stem cell transplant?
- Could a liquid form of a Graft-Versus-Host disease drug be as effective as the pill?
- Can a cancer drug tame graft-versus-host disease when steroids fail?
- Scientists map immune battlefield in chronic GVHD tissue
- New antibody may offer safer shield against transplant complications
- Could a rheumatoid arthritis drug tame chronic GVHD and cut steroid use?